Pulmonary valve insufficiency

disease
On this page

Also known as pulmonary regurgitationpulmonary valve regurgitationpulmonary valvular regurgitationregurgitation, pulmonary

Summary

Pulmonary valve insufficiency (MONDO:0001927) is a disease and 28 clinical trials. A subtype of pulmonary valve disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 28

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namepulmonary valve insufficiency
Mondo IDMONDO:0001927
MeSHD011665
DOIDDOID:14265
ICD-111093888988
NCITC50848
SNOMED CT194995005
UMLSC0034088
MedGen11031
Is cancer (heuristic)no

Also known as: pulmonary regurgitation · pulmonary valve regurgitation · pulmonary valvular regurgitation · regurgitation, pulmonary

Disease family

This is a subtype of pulmonary valve disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › cardiovascular disorderheart disorderheart valve disorderpulmonary valve disorderpulmonary valve insufficiency

Related subtypes (2): rheumatic pulmonary valve disease, pulmonary valve stenosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 28.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified25
PHASE41
PHASE31
PHASE2/PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT06668389PHASE4RECRUITINGSodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
NCT00259207PHASE3COMPLETEDPulmonary Valve Replacement in Large Right Ventricular Outflow Tract
NCT02590679PHASE2/PHASE3UNKNOWNMulti-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p
NCT02744677Not specifiedRECRUITINGCOMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
NCT02979587Not specifiedACTIVE_NOT_RECRUITINGThe Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
NCT03130777Not specifiedACTIVE_NOT_RECRUITINGALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
NCT03441971Not specifiedACTIVE_NOT_RECRUITINGEvaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
NCT03983512Not specifiedACTIVE_NOT_RECRUITINGPULSTA Transcatheter Pulmonary Valve Pre-Approval Study
NCT04084132Not specifiedRECRUITINGEarly Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation
NCT04570163Not specifiedRECRUITINGBerlin Registry of Right Heart Interventions
NCT04860765Not specifiedACTIVE_NOT_RECRUITINGCOMPASSION S3 Post-Approval Study
NCT05077774Not specifiedACTIVE_NOT_RECRUITINGHarmony TPV Post-Approval Study
NCT05378386Not specifiedACTIVE_NOT_RECRUITINGALTERRA Post-Approval Study
NCT05809856Not specifiedRECRUITINGFeasibility Study to Evaluate the Safety of the Autologous GrOwnValve Transcatheter Pulmonary Heart Valve
NCT06010563Not specifiedRECRUITINGVenusP-Valve Pivotal Study (PROTEUS STUDY)
NCT06906926Not specifiedRECRUITINGHarmony TPV EMEA PMS
NCT00112320Not specifiedCOMPLETEDComparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of Fallot
NCT00676689Not specifiedCOMPLETEDCOMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
NCT01092442Not specifiedCOMPLETEDCryoValve SG Pulmonary Human Heart Valve Post Clearance Study
NCT01356108Not specifiedCOMPLETEDPulmonic Valve REplacement Multi-discIpline EMEA Registry
NCT01824160Not specifiedCOMPLETEDPulmonary Artery Repair With Covered Stents
NCT02555319Not specifiedCOMPLETEDA Feasibility Study to Evaluate the Safety and Short-term Effectiveness of Transcatheter Pulmonary Valve (TPV)
NCT02656290Not specifiedCOMPLETEDCOMMENCE Pulmonary: Clinical Evaluation of Edwards Pericardial Aortic Bioprosthesis (Model 11000A) for Pulmonary Valve Replacement
NCT02846753Not specifiedUNKNOWNImplantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts
NCT02987387Not specifiedCOMPLETEDCOMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction
NCT03471936Not specifiedUNKNOWNRight Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease
NCT04205461Not specifiedUNKNOWNProspective Evaluation of Programmed Ventricular Stimulation Before Pulmonary Valve Replacement in Patients With Tetralogy of Fallot
NCT05090228Not specifiedCOMPLETEDRight Ventricle Remodeling After Pulmonary Valve Replacement and Percutaneous Pulmonary Valve Insertion

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.